nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Hypertensive—Octreotide—thymus cancer	0.0685	0.0857	CcSEcCtD
Doxazosin—KCNH6—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0473	0.244	CbGpPWpGaD
Doxazosin—KCNH7—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0421	0.217	CbGpPWpGaD
Doxazosin—Hypertension worsened—Octreotide—thymus cancer	0.0362	0.0452	CcSEcCtD
Doxazosin—Breast neoplasm—Octreotide—thymus cancer	0.0262	0.0327	CcSEcCtD
Doxazosin—KCNH6—Potassium Channels—KCNA4—thymus cancer	0.0243	0.125	CbGpPWpGaD
Doxazosin—KCNH7—Potassium Channels—KCNA4—thymus cancer	0.0216	0.111	CbGpPWpGaD
Doxazosin—Rectal tenesmus—Octreotide—thymus cancer	0.0212	0.0265	CcSEcCtD
Doxazosin—Hepatitis cholestatic—Octreotide—thymus cancer	0.0196	0.0245	CcSEcCtD
Doxazosin—Prostatic disorder—Octreotide—thymus cancer	0.0186	0.0232	CcSEcCtD
Doxazosin—KCNH2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0178	0.092	CbGpPWpGaD
Doxazosin—Proctalgia—Octreotide—thymus cancer	0.0168	0.0211	CcSEcCtD
Doxazosin—Hernia—Octreotide—thymus cancer	0.0168	0.0211	CcSEcCtD
Doxazosin—Renal pain—Octreotide—thymus cancer	0.015	0.0188	CcSEcCtD
Doxazosin—Anorectal discomfort—Octreotide—thymus cancer	0.0144	0.0181	CcSEcCtD
Doxazosin—Cholelithiasis—Octreotide—thymus cancer	0.0127	0.0159	CcSEcCtD
Doxazosin—Nail disorder—Octreotide—thymus cancer	0.0122	0.0152	CcSEcCtD
Doxazosin—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0116	0.0145	CcSEcCtD
Doxazosin—Influenza-like symptoms—Octreotide—thymus cancer	0.0111	0.0138	CcSEcCtD
Doxazosin—KCNH6—Neuronal System—KCNA4—thymus cancer	0.0106	0.0546	CbGpPWpGaD
Doxazosin—Herpes zoster—Octreotide—thymus cancer	0.0105	0.0131	CcSEcCtD
Doxazosin—Cholestasis—Octreotide—thymus cancer	0.0104	0.013	CcSEcCtD
Doxazosin—Otitis media—Octreotide—thymus cancer	0.0101	0.0127	CcSEcCtD
Doxazosin—Nephrolithiasis—Octreotide—thymus cancer	0.00983	0.0123	CcSEcCtD
Doxazosin—KCNH7—Neuronal System—KCNA4—thymus cancer	0.00944	0.0486	CbGpPWpGaD
Doxazosin—Neoplasm malignant—Octreotide—thymus cancer	0.00925	0.0116	CcSEcCtD
Doxazosin—KCNH2—Potassium Channels—KCNA4—thymus cancer	0.00915	0.0472	CbGpPWpGaD
Doxazosin—Breast pain—Octreotide—thymus cancer	0.00905	0.0113	CcSEcCtD
Doxazosin—Rectal haemorrhage—Octreotide—thymus cancer	0.00875	0.0109	CcSEcCtD
Doxazosin—Viral infection—Octreotide—thymus cancer	0.00875	0.0109	CcSEcCtD
Doxazosin—Herpes simplex—Octreotide—thymus cancer	0.00857	0.0107	CcSEcCtD
Doxazosin—Muscle twitching—Octreotide—thymus cancer	0.00804	0.0101	CcSEcCtD
Doxazosin—Cystitis noninfective—Octreotide—thymus cancer	0.00772	0.00965	CcSEcCtD
Doxazosin—Influenza like illness—Octreotide—thymus cancer	0.00767	0.00959	CcSEcCtD
Doxazosin—Cystitis—Octreotide—thymus cancer	0.00763	0.00954	CcSEcCtD
Doxazosin—Cramps of lower extremities—Octreotide—thymus cancer	0.00726	0.00908	CcSEcCtD
Doxazosin—Urine output increased—Octreotide—thymus cancer	0.00714	0.00893	CcSEcCtD
Doxazosin—Bladder pain—Octreotide—thymus cancer	0.00714	0.00893	CcSEcCtD
Doxazosin—Gynaecomastia—Octreotide—thymus cancer	0.00707	0.00884	CcSEcCtD
Doxazosin—Polyuria—Octreotide—thymus cancer	0.00653	0.00817	CcSEcCtD
Doxazosin—Gastroenteritis—Octreotide—thymus cancer	0.00647	0.00809	CcSEcCtD
Doxazosin—Deafness—Octreotide—thymus cancer	0.00641	0.00802	CcSEcCtD
Doxazosin—Hot flush—Octreotide—thymus cancer	0.00613	0.00767	CcSEcCtD
Doxazosin—Amnesia—Octreotide—thymus cancer	0.0061	0.00763	CcSEcCtD
Doxazosin—Menopausal symptoms—Octreotide—thymus cancer	0.00608	0.0076	CcSEcCtD
Doxazosin—Arthritis—Octreotide—thymus cancer	0.0059	0.00738	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00573	0.00717	CcSEcCtD
Doxazosin—Dehydration—Octreotide—thymus cancer	0.00533	0.00667	CcSEcCtD
Doxazosin—Dry skin—Octreotide—thymus cancer	0.00526	0.00657	CcSEcCtD
Doxazosin—Cramp muscle—Octreotide—thymus cancer	0.00516	0.00646	CcSEcCtD
Doxazosin—Muscular weakness—Octreotide—thymus cancer	0.00506	0.00632	CcSEcCtD
Doxazosin—Abdominal distension—Octreotide—thymus cancer	0.00499	0.00624	CcSEcCtD
Doxazosin—Bronchospasm—Octreotide—thymus cancer	0.00488	0.0061	CcSEcCtD
Doxazosin—Sweating increased—Octreotide—thymus cancer	0.00483	0.00604	CcSEcCtD
Doxazosin—Bronchitis—Octreotide—thymus cancer	0.00477	0.00596	CcSEcCtD
Doxazosin—Abdominal discomfort—Octreotide—thymus cancer	0.00475	0.00594	CcSEcCtD
Doxazosin—Dysuria—Octreotide—thymus cancer	0.00463	0.0058	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Octreotide—thymus cancer	0.00461	0.00576	CcSEcCtD
Doxazosin—Pollakiuria—Octreotide—thymus cancer	0.00458	0.00573	CcSEcCtD
Doxazosin—Weight increased—Octreotide—thymus cancer	0.00451	0.00564	CcSEcCtD
Doxazosin—Weight decreased—Octreotide—thymus cancer	0.00448	0.00561	CcSEcCtD
Doxazosin—Hyperglycaemia—Octreotide—thymus cancer	0.00447	0.00559	CcSEcCtD
Doxazosin—Pneumonia—Octreotide—thymus cancer	0.00444	0.00556	CcSEcCtD
Doxazosin—Drowsiness—Octreotide—thymus cancer	0.00442	0.00553	CcSEcCtD
Doxazosin—Depression—Octreotide—thymus cancer	0.00441	0.00551	CcSEcCtD
Doxazosin—Jaundice—Octreotide—thymus cancer	0.00431	0.00539	CcSEcCtD
Doxazosin—Urinary tract infection—Octreotide—thymus cancer	0.0043	0.00537	CcSEcCtD
Doxazosin—Conjunctivitis—Octreotide—thymus cancer	0.0043	0.00537	CcSEcCtD
Doxazosin—Haematuria—Octreotide—thymus cancer	0.00421	0.00527	CcSEcCtD
Doxazosin—Epistaxis—Octreotide—thymus cancer	0.00417	0.00521	CcSEcCtD
Doxazosin—Sinusitis—Octreotide—thymus cancer	0.00415	0.00518	CcSEcCtD
Doxazosin—Bradycardia—Octreotide—thymus cancer	0.00404	0.00505	CcSEcCtD
Doxazosin—KCNH2—Neuronal System—KCNA4—thymus cancer	0.004	0.0206	CbGpPWpGaD
Doxazosin—Rhinitis—Octreotide—thymus cancer	0.00398	0.00497	CcSEcCtD
Doxazosin—Hepatitis—Octreotide—thymus cancer	0.00397	0.00496	CcSEcCtD
Doxazosin—Hypoaesthesia—Octreotide—thymus cancer	0.00395	0.00494	CcSEcCtD
Doxazosin—Pharyngitis—Octreotide—thymus cancer	0.00394	0.00492	CcSEcCtD
Doxazosin—Visual impairment—Octreotide—thymus cancer	0.00382	0.00478	CcSEcCtD
Doxazosin—Tinnitus—Octreotide—thymus cancer	0.0037	0.00463	CcSEcCtD
Doxazosin—Flushing—Octreotide—thymus cancer	0.00368	0.0046	CcSEcCtD
Doxazosin—Arrhythmia—Octreotide—thymus cancer	0.00354	0.00443	CcSEcCtD
Doxazosin—Alopecia—Octreotide—thymus cancer	0.00351	0.00438	CcSEcCtD
Doxazosin—Mental disorder—Octreotide—thymus cancer	0.00348	0.00435	CcSEcCtD
Doxazosin—Malnutrition—Octreotide—thymus cancer	0.00345	0.00432	CcSEcCtD
Doxazosin—Flatulence—Octreotide—thymus cancer	0.0034	0.00426	CcSEcCtD
Doxazosin—Tension—Octreotide—thymus cancer	0.00339	0.00424	CcSEcCtD
Doxazosin—Nervousness—Octreotide—thymus cancer	0.00335	0.00419	CcSEcCtD
Doxazosin—Back pain—Octreotide—thymus cancer	0.00334	0.00418	CcSEcCtD
Doxazosin—Muscle spasms—Octreotide—thymus cancer	0.00332	0.00415	CcSEcCtD
Doxazosin—Vision blurred—Octreotide—thymus cancer	0.00325	0.00407	CcSEcCtD
Doxazosin—Tremor—Octreotide—thymus cancer	0.00324	0.00405	CcSEcCtD
Doxazosin—Ill-defined disorder—Octreotide—thymus cancer	0.0032	0.00401	CcSEcCtD
Doxazosin—Agitation—Octreotide—thymus cancer	0.00317	0.00397	CcSEcCtD
Doxazosin—Malaise—Octreotide—thymus cancer	0.00311	0.00389	CcSEcCtD
Doxazosin—Vertigo—Octreotide—thymus cancer	0.0031	0.00388	CcSEcCtD
Doxazosin—Syncope—Octreotide—thymus cancer	0.0031	0.00387	CcSEcCtD
Doxazosin—Palpitations—Octreotide—thymus cancer	0.00305	0.00382	CcSEcCtD
Doxazosin—Loss of consciousness—Octreotide—thymus cancer	0.00304	0.0038	CcSEcCtD
Doxazosin—Cough—Octreotide—thymus cancer	0.00301	0.00377	CcSEcCtD
Doxazosin—Convulsion—Octreotide—thymus cancer	0.00299	0.00374	CcSEcCtD
Doxazosin—Hypertension—Octreotide—thymus cancer	0.00298	0.00373	CcSEcCtD
Doxazosin—Arthralgia—Octreotide—thymus cancer	0.00294	0.00368	CcSEcCtD
Doxazosin—Myalgia—Octreotide—thymus cancer	0.00294	0.00368	CcSEcCtD
Doxazosin—Chest pain—Octreotide—thymus cancer	0.00294	0.00368	CcSEcCtD
Doxazosin—Anxiety—Octreotide—thymus cancer	0.00293	0.00366	CcSEcCtD
Doxazosin—Discomfort—Octreotide—thymus cancer	0.0029	0.00363	CcSEcCtD
Doxazosin—Dry mouth—Octreotide—thymus cancer	0.00288	0.0036	CcSEcCtD
Doxazosin—Oedema—Octreotide—thymus cancer	0.00282	0.00352	CcSEcCtD
Doxazosin—Infection—Octreotide—thymus cancer	0.0028	0.0035	CcSEcCtD
Doxazosin—Shock—Octreotide—thymus cancer	0.00277	0.00347	CcSEcCtD
Doxazosin—Thrombocytopenia—Octreotide—thymus cancer	0.00276	0.00345	CcSEcCtD
Doxazosin—Tachycardia—Octreotide—thymus cancer	0.00275	0.00344	CcSEcCtD
Doxazosin—Skin disorder—Octreotide—thymus cancer	0.00274	0.00342	CcSEcCtD
Doxazosin—Hyperhidrosis—Octreotide—thymus cancer	0.00272	0.00341	CcSEcCtD
Doxazosin—Anorexia—Octreotide—thymus cancer	0.00269	0.00336	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00257	0.00321	CcSEcCtD
Doxazosin—Insomnia—Octreotide—thymus cancer	0.00255	0.00319	CcSEcCtD
Doxazosin—Paraesthesia—Octreotide—thymus cancer	0.00253	0.00316	CcSEcCtD
Doxazosin—Dyspnoea—Octreotide—thymus cancer	0.00251	0.00314	CcSEcCtD
Doxazosin—Somnolence—Octreotide—thymus cancer	0.00251	0.00313	CcSEcCtD
Doxazosin—Dyspepsia—Octreotide—thymus cancer	0.00248	0.0031	CcSEcCtD
Doxazosin—Decreased appetite—Octreotide—thymus cancer	0.00245	0.00306	CcSEcCtD
Doxazosin—Fatigue—Octreotide—thymus cancer	0.00243	0.00304	CcSEcCtD
Doxazosin—Constipation—Octreotide—thymus cancer	0.00241	0.00301	CcSEcCtD
Doxazosin—Pain—Octreotide—thymus cancer	0.00241	0.00301	CcSEcCtD
Doxazosin—Feeling abnormal—Octreotide—thymus cancer	0.00232	0.0029	CcSEcCtD
Doxazosin—Gastrointestinal pain—Octreotide—thymus cancer	0.0023	0.00288	CcSEcCtD
Doxazosin—Urticaria—Octreotide—thymus cancer	0.00224	0.0028	CcSEcCtD
Doxazosin—Body temperature increased—Octreotide—thymus cancer	0.00223	0.00279	CcSEcCtD
Doxazosin—Abdominal pain—Octreotide—thymus cancer	0.00223	0.00279	CcSEcCtD
Doxazosin—Hypersensitivity—Octreotide—thymus cancer	0.00208	0.0026	CcSEcCtD
Doxazosin—Asthenia—Octreotide—thymus cancer	0.00202	0.00253	CcSEcCtD
Doxazosin—Pruritus—Octreotide—thymus cancer	0.00199	0.00249	CcSEcCtD
Doxazosin—Diarrhoea—Octreotide—thymus cancer	0.00193	0.00241	CcSEcCtD
Doxazosin—Dizziness—Octreotide—thymus cancer	0.00186	0.00233	CcSEcCtD
Doxazosin—Vomiting—Octreotide—thymus cancer	0.00179	0.00224	CcSEcCtD
Doxazosin—Rash—Octreotide—thymus cancer	0.00178	0.00222	CcSEcCtD
Doxazosin—Dermatitis—Octreotide—thymus cancer	0.00178	0.00222	CcSEcCtD
Doxazosin—Headache—Octreotide—thymus cancer	0.00177	0.00221	CcSEcCtD
Doxazosin—Nausea—Octreotide—thymus cancer	0.00167	0.00209	CcSEcCtD
Doxazosin—KCNH7—Circadian rythm related genes—TP53—thymus cancer	0.000752	0.00388	CbGpPWpGaD
Doxazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.000744	0.00383	CbGpPWpGaD
Doxazosin—KCNH6—lung—thymus cancer	0.000568	0.0898	CbGeAlD
Doxazosin—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—thymus cancer	0.000514	0.00265	CbGpPWpGaD
Doxazosin—ADRA1D—epithelium—thymus cancer	0.000496	0.0783	CbGeAlD
Doxazosin—ADRA1B—AMPK Signaling—TP53—thymus cancer	0.000448	0.00231	CbGpPWpGaD
Doxazosin—ORM1—hematopoietic system—thymus cancer	0.000447	0.0706	CbGeAlD
Doxazosin—ADRA1B—LPA receptor mediated events—AKT1—thymus cancer	0.000402	0.00207	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—TP53—thymus cancer	0.000398	0.00205	CbGpPWpGaD
Doxazosin—ADRA1B—AMPK Signaling—AKT1—thymus cancer	0.000378	0.00195	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000357	0.00184	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—AKT1—thymus cancer	0.000336	0.00173	CbGpPWpGaD
Doxazosin—CYP2C19—hematopoietic system—thymus cancer	0.000315	0.0498	CbGeAlD
Doxazosin—ADRA1A—hematopoietic system—thymus cancer	0.000311	0.0492	CbGeAlD
Doxazosin—KCNH2—hematopoietic system—thymus cancer	0.000301	0.0475	CbGeAlD
Doxazosin—ORM1—bone marrow—thymus cancer	0.000286	0.0452	CbGeAlD
Doxazosin—ADRA1A—epithelium—thymus cancer	0.000285	0.045	CbGeAlD
Doxazosin—ORM1—lung—thymus cancer	0.000259	0.041	CbGeAlD
Doxazosin—ADRA2A—hematopoietic system—thymus cancer	0.000237	0.0374	CbGeAlD
Doxazosin—KCNH2—cardiac atrium—thymus cancer	0.000228	0.0361	CbGeAlD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000227	0.00117	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000224	0.00115	CbGpPWpGaD
Doxazosin—KCNH2—pituitary gland—thymus cancer	0.000223	0.0353	CbGeAlD
Doxazosin—ADRA1A—lymphoid tissue—thymus cancer	0.000219	0.0347	CbGeAlD
Doxazosin—KCNH2—bone marrow—thymus cancer	0.000193	0.0305	CbGeAlD
Doxazosin—CYP2D6—hematopoietic system—thymus cancer	0.000183	0.029	CbGeAlD
Doxazosin—ADRA2A—cardiac atrium—thymus cancer	0.00018	0.0284	CbGeAlD
Doxazosin—ADRA1D—Signaling Pathways—MAML2—thymus cancer	0.000178	0.000918	CbGpPWpGaD
Doxazosin—ORM1—lymph node—thymus cancer	0.000177	0.028	CbGeAlD
Doxazosin—ADRA2A—pituitary gland—thymus cancer	0.000176	0.0278	CbGeAlD
Doxazosin—ADRA2A—thyroid gland—thymus cancer	0.000151	0.0239	CbGeAlD
Doxazosin—ADRA1B—Signaling Pathways—MAML2—thymus cancer	0.000148	0.000762	CbGpPWpGaD
Doxazosin—ADRA2A—lung—thymus cancer	0.000138	0.0217	CbGeAlD
Doxazosin—ABCB1—hematopoietic system—thymus cancer	0.000132	0.0209	CbGeAlD
Doxazosin—ADRA1A—Signaling Pathways—MAML2—thymus cancer	0.000131	0.000677	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thymus cancer	0.000123	0.000634	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAML2—thymus cancer	0.000122	0.000629	CbGpPWpGaD
Doxazosin—ABCB1—epithelium—thymus cancer	0.000121	0.0191	CbGeAlD
Doxazosin—KCNH2—lymph node—thymus cancer	0.000119	0.0189	CbGeAlD
Doxazosin—ADRA2A—Hemostasis—IL2—thymus cancer	0.000117	0.000603	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000113	0.000583	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2—thymus cancer	0.000108	0.000556	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2—thymus cancer	9.79e-05	0.000505	CbGpPWpGaD
Doxazosin—ABCB1—pituitary gland—thymus cancer	9.79e-05	0.0155	CbGeAlD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	9.55e-05	0.000493	CbGpPWpGaD
Doxazosin—ADRA2A—lymph node—thymus cancer	9.41e-05	0.0149	CbGeAlD
Doxazosin—ABCB1—lymphoid tissue—thymus cancer	9.29e-05	0.0147	CbGeAlD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—thymus cancer	8.95e-05	0.000461	CbGpPWpGaD
Doxazosin—ABCB1—bone marrow—thymus cancer	8.46e-05	0.0134	CbGeAlD
Doxazosin—ABCB1—thyroid gland—thymus cancer	8.44e-05	0.0133	CbGeAlD
Doxazosin—ADRA1D—Signaling Pathways—KIT—thymus cancer	8.22e-05	0.000424	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—thymus cancer	8.13e-05	0.000419	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—thymus cancer	7.95e-05	0.00041	CbGpPWpGaD
Doxazosin—ABCB1—lung—thymus cancer	7.66e-05	0.0121	CbGeAlD
Doxazosin—ADRA2A—Hemostasis—TP53—thymus cancer	7.51e-05	0.000387	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—thymus cancer	7.39e-05	0.000381	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—thymus cancer	7.22e-05	0.000372	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KIT—thymus cancer	6.82e-05	0.000352	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—thymus cancer	6.71e-05	0.000346	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—thymus cancer	6.34e-05	0.000327	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—thymus cancer	6.06e-05	0.000312	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—thymus cancer	5.85e-05	0.000301	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—thymus cancer	5.78e-05	0.000298	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—thymus cancer	5.63e-05	0.00029	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—thymus cancer	5.31e-05	0.000274	CbGpPWpGaD
Doxazosin—ABCB1—lymph node—thymus cancer	5.24e-05	0.00828	CbGeAlD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—thymus cancer	4.85e-05	0.00025	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—thymus cancer	4.8e-05	0.000248	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—thymus cancer	4.41e-05	0.000227	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—thymus cancer	4.31e-05	0.000222	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—thymus cancer	4.26e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—thymus cancer	4.01e-05	0.000206	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—thymus cancer	3.96e-05	0.000204	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—thymus cancer	3.91e-05	0.000202	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—thymus cancer	3.71e-05	0.000191	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—thymus cancer	3.64e-05	0.000188	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—thymus cancer	3.14e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—thymus cancer	3.08e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—thymus cancer	2.74e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—thymus cancer	2.6e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—thymus cancer	2.57e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—thymus cancer	2.54e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—thymus cancer	2.31e-05	0.000119	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—thymus cancer	2.15e-05	0.000111	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—thymus cancer	1.82e-05	9.38e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—thymus cancer	1.78e-05	9.16e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—thymus cancer	1.67e-05	8.63e-05	CbGpPWpGaD
